The Role of Brentuximab Vedotin (BV) as Second-Line Treatment of Refractory Classical Hodgkin Lymphoma (cHL) in the Era of Pandemic COVID-19
Wulyo Rajabto,1,2 Vitya Chandika,1 Agnes Stephanie Harahap,3 Maria Francisca Ham3 1Division of Hematology-Medical Oncology, Department of Internal Medicine, Dr. Cipto Mangunkusumo General Hospital/ Faculty of Medicine Universitas Indonesia, Central Jakarta, Indonesia; 2Department of Internal Medicin...
Bewaard in:
| Hoofdauteurs: | , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Dove Medical Press
2022-06-01
|
| Reeks: | International Medical Case Reports Journal |
| Onderwerpen: | |
| Online toegang: | https://www.dovepress.com/the-role-of-brentuximab-vedotin-bv-as-second-line-treatment-of-refract-peer-reviewed-fulltext-article-IMCRJ |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|